BSD Medical Corp
(NASDAQ: BSDM)
+0.02
+1.75%
| Exchange: | NASDAQ |
| Stock: | BSD Medical Corporation |
| Industry: | NA |
| Employees: | 48 |
| BSD Medical Corporation (BSD) develops, manufactures, markets and services systems to treat cancer and delivers using focused radiofrequency (RF) and microwave energy. BSD business focuses to commercialize the products for the treatment of cancer and to expand the products to treat other diseases and medical conditions. The Company’s product line for cancer therapy offers hospitals and clinics a solution for thermal treatment of cancer using microwave/RF systems. It uses microwave thermal therapy for the treatment of symptoms associated with enlarged prostate. Its product line includes systems that have been designed to offer a range of thermal treatment systems for the treatment of cancer, including both ablation and hyperthermia treatment systems. Its hyperthermia cancer treatment systems are used to treat cancer with heat (hyperthermia). In January 2013, it East Coast academic medical center (the Center) purchased a BSD-500 Hyperthermia System (BSD-500). |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
